Dennis E. Marshall - 28 Dec 2022 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Reporting relationship: Director
Issuer ticker: BLGO
Reported as of: 28 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Dec 2022, 19:42:59 UTC
Prior SEC filing: 05 Oct 2022
Next SEC filing: 04 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ John R. Browning, Attorney-in-fact

Key filing fact

Dennis E. Marshall filed Form 4 for BIOLARGO, INC. (BLGO) on 29 Dec 2022.

Key facts

This page summarizes Dennis E. Marshall's Form 4 filing for BIOLARGO, INC. (BLGO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 29 Dec 2022, 19:42.

Change

Previous filing in this sequence was filed on 05 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BLGO transaction Derivative

Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +37,500
Change %: +1.1%
Price: $0.000000
Shares after: 3,590,354
Date: 28 Dec 2022
Ownership: Direct
Underlying class: Common stock
Underlying amount: 37,500
Exercise price: $0.1689
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This Option was granted to Reporting Person to replace an option previously issued to compensate Reporting Person for services to the Issuer, which expired, unexercised, due to a discrepancy between the original exercise price and current stock price of the Issuer, pursuant to plan adopted by the Issuer's Compensation Committee and Board of Directors.

Footnote F2

Reflects the December 28, 2022, expiration of an option to purchase 75,000 shares.